CRESSKILL, N.J., Nov. 9, 2017 /PRNewswire/ — An innovative, investigational treatment approach is showing the potential to address an important, unresolved problem encountered by patients with kidney failure on dialysis. At the recent annual meeting of the American Society of Nephrology (ASN), Vascular Therapies, Inc. presented preliminary results relating to analysis of the first 18 […]
Tag: AV Fistula
C. R. Bard, Inc. (BCR) Snags FDA Premarket Approval of The Lutonix 035 Drug Coated Balloon As The First And Only DCB
C. R. Bard Receives Fda Premarket Approval Of The Lutonix® 035 Drug Coated Balloon As The First And Only Dcb For The Treatment Of Patients With Dysfunctional Av Fistulae New Option to Preserve Vascular Access and Help Hemodialysis Patients Extend Time Between Reinterventions MURRAY HILL, N.J.–(BUSINESS WIRE)–C. R. Bard, Inc. (NYSE:BCR) today announced the LUTONIX® […]
Laminate Medical Technologies Receives IDE Approval From FDA To Initiate Clinical Study Of The VasQ Device
TEL AVIV, Israel–(BUSINESS WIRE)–Laminate Medical Technologies (Laminate), an Israeli biomedical start-up developing VasQ, an implanted blood vessel external support device for patients requiring arteriovenous fistula as vascular access for hemodialysis, today announced that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA). IDE approval allows Laminate to evaluate the […]